An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15)

NCT05477524 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

12547

Enrollment

INDUSTRY

Sponsor class

Conditions

Lyme Disease

Interventions

BIOLOGICAL: VLA15
OTHER: Saline

Sponsor

Pfizer

Collaborators

[object Object]